the

Final Remediation Update Regarding The Flow Security Incident: 87.4 Billion Counterfeit Tokens have Been Destroyed

George Town, Cayman Island, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Counterfeit Token Destruction Complete Flow Foundation today confirmed the permanent…

2 months ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since 2018, has decided to pursue…

2 months ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive November 2025 fire at Keswick…

2 months ago

Think Tank Report The Jiangsu Practice of Humanomics Released

NANJING, China, Jan. 30, 2026 /PRNewswire/ -- On January 30, Xinhua News Agency Jiangsu Branch released the think tank report…

2 months ago

The Shaw Prize Adds Computer Science in Landmark Expansion

HONG KONG, Jan. 28, 2026 /PRNewswire/ -- The Shaw Prize Foundation announced its first major expansion in over two decades: the…

2 months ago

Bybit Unveils 2026 Vision as “The New Financial Platform,” Expanding Beyond Exchange Into Global Financial Infrastructure

DUBAI, UAE, Jan. 30, 2026 /PRNewswire/ -- Bybit, the world's second-largest crypto exchange by trading volume, today announced its 2026…

2 months ago

India Signals Shift from AI Vision to Sovereign Execution with the launch of IAIRO

~ The execution engine for India's AI strategy ~NEW DELHI, Jan. 30, 2026 /PRNewswire/ -- A decisive shift in India's…

2 months ago

Mantle’s Cross-Chain Era on Solana: Onboarding the Bybit Express to Mantle Super Portal

DUBAI, UAE, Jan. 30, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is excited to join Mantle's…

2 months ago

Press Release: Sanofis Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease

Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation supported by safety and efficacy…

2 months ago

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed…

2 months ago